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Abstract
Introduction: The drugs gabapentin and ketamine are used frequently in the peri-operative setting. There is poor
documentation whether or not gabapentin and ketamine interact to cause prolonged depression of the central
nervous system.
Case Presentation: The following is a case report in which a patient, a 58-year-old African-American man, with a
history of post-traumatic stress disorder and chronic pain underwent a cervical laminoplasty procedure. The patient
presented post-operatively in a dissociative state with paralysis, anarthria and preservation of consciousness. All
organic causes were excluded, with the exception of prolonged central nervous system depression from a
gabapentin/ketamine drug interaction. A new onset conversion disorder could also not be excluded.
Conclusion: Although this case by itself is not enough evidence to substantiate a true adverse reaction between
gabapentin and ketamine, it is enough to warrant further investigation.
Introduction
The incidence of post-traumatic stress disorder (PTSD)
is undoubtedly on the rise, given the recent events of
the World Trade Center and Pentagon terrorist attacks
coupled with the current wars in Iraq and Afghanistan.
The prevalence of PTSD in the United States population
is estimated to be approximately 8%. According to the
Veterans Health Administration (VHA), Operation Iraqi
Freedom (OIF) and Operation Enduring Freedom (OEF)
veterans seeking VHA health care have been diagnosed
predominantly with PTSD [1,2].
PTSD can give rise to pain as suggested by the high
rates of chronic pain in patients with a history of child-
hood abuse [3]. Gabapentin and ketamine have indepen-
dently shown improvement in chronic pain associated
with PTSD [3-5]. Unfortunately, however, there is little
documented evidence to suggest that gabapentin and
ketamine interact to additively or synergistically depress
the central nervous system (CNS) and/or have respira-
tory-depressant effects, especially in elderly or debili-
tated patients [6].
The following is a case report in which a patient with
a history of PTSD and chronic pain underwent a cervi-
cal laminoplasty procedure. Our patient presented post-
operatively in a dissociative state with paralysis, anar-
thria (loss of articulate speech), and preservation of con-
sciousness. All organic causes were excluded, with the
exception of prolonged CNS depression from a gaba-
pentin/ketamine drug interaction. A new onset conver-
sion disorder could also not be excluded.
Case presentation
A 58-year-old African-American man presented to our
neurosurgery clinic for cervical spinal stenosis. He had
an approximate one-year history of slowly declining
ability to ambulate, chronic pain in both hands, as well
as mild paresthesias and decreased sensation involving
fingers on both hands. Additionally, he described grip
weakness, greater in his left than right. Both computed
tomography (CT) and magnetic resonance imaging
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(MRI) revealed multi-level degenerative disc disease,
causing narrowing of his spinal canal at cervical levels
3-7 (C3-C7) (Figure 1). Given our patient’s clinical pre-
sentation and radiographic evidence of cervical spinal
stenosis, he was scheduled for a C3-C7 laminoplasty for
spondylosis and myelopathy.
Our patient’s past medical history was significant for
non-insulin dependent diabetes mellitus, asthma, hyper-
tension, benign prostatic hypertrophy, gastro-esophageal
reflux disease, deep venous thrombosis, post-traumatic
stress disorder, insomnia, chronic pain, and obstructive
sleep apnea. For these disorders his medication regimen
included metformin, budesonide and formoterol fuma-
rate dihydrate, albuterol, lisinopril, hydrochlorothiazide,
tolterodine tartrate, omeprazole, warfarin sodium, gaba-
pentin, zolpidem tartrate, ferrous sulfate, and senna, on
a daily basis. He used 900 mg gabapentin three times a
day. Our patient did not drink or smoke, and reported
allergies to aspirin and peanuts, which caused hives.
On clinical exam, he was alert and oriented in all
hemispheres. Cranial nerves II-XII were grossly intact.
His peripheral neurological exam revealed decreased
sensation to light touch and pinprick in both hands and
feet. His muscular strength was 4+/5 in his bilateral del-
toids, biceps and triceps, 4/5 in his bilateral wrist exten-
sors, 4/5 in his right finger abductors, 3/5 in his left
finger abductors, 4/5 in his bilateral finger flexors, and 4
+/5 in his bilateral lower extremities. He showed no
pre-operative co-ordination and/or cerebellum abnorm-
alities. Physical examination revealed 3/4 hyper-reflexia
in all four extremities. He was Hoffman positive on his
right side and Hoffman negative on his left.
Our patient was evaluated by the anesthesia service
and medicine services prior to surgery. He did not take
metformin, warfarin sodium, or zolpidem tartrate the
day before. He did, however, take 900 mg gabapentin up
until the morning of his surgery.
Pre-operatively, he was given 1 mg midazolam. He
was taken to our operating room and placed under gen-
eral anesthesia with oral endo-tracheal intubation for
C3-C7 laminotomy. Our patient’s general anesthetic
consisted of an initial 100 mg intubating dose of succi-
nylcholine followed by total intravenous anesthesia
(TIVA) using propofol, ketamine, and fentanyl. A total
of 100 mg ketamine was used throughout the entire
procedure. Neuromuscular monitoring was performed
during the case and remained without any significant
concerns. Our patient’s intra-operative fluid balance
included 2400 mL Ringer’s Lactate and urine output of
300 mL, with 150 mL blood loss during the three hour
and fifty minute case.
Our patient’s hemodynamics remained stable through-
out the entire case with mean arterial pressures (MAP)
maintained at approximately 100 mmHg according to
the surgeon’s request. At the end of the case, although
breathing spontaneously, our patient was not responsive
to verbal or noxious stimuli. After being given three
separate doses of 40 μg IV naloxone, our patient was
moving his arms with anti-gravity strength. He was
extubated and taken to the post-anesthesia care unit
(PACU) for recovery.
In the PACU, our patient was not moving his upper
or lower extremities and his verbal response consisted
of “aha” or blowing through pursed lips. His pupils
remained equal and reactive to light. When asked to
respond by blinking, our patient would blink uncon-
trollably. His extremities were flaccid and areflexic.
Our patient’s vitals remained stable and oxygen satura-
tion was 100%. His arterial blood gas was obtained and
was normal, except for partial carbon dioxide (pCO2)
of 50 mmHg. No electrolyte abnormalities were
detected. A urine analysis was within normal limits,
along with glucose, ammonia, and lactate levels. Motor
evoke potentials were rechecked and remained
unchanged from pre-operative values. It was then
decided to obtain a CT of the head and neck region
(Figures 2 and 3).
After over two hours of being inappropriately non-
responsive to verbal and tactile stimuli in the PACU,
our patient was given an additional 400 μg of IV nalox-
one over a 10 minute period. He was then transferred
to the Intensive Care Unit (ICU) for close monitoring
and care. MRI and angiography revealed a normal Circle
of Willis and no evidence of post-surgical complications
in the cervical spine after the C3-C7 decompression
(Figures 4 and 5).
Figure 1 Sagittal T2-weighted MRI showing narrowing of
spinal canal at C3-C7.
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In the ICU, blood and imaging studies continued to be
unremarkable. Our patient continued to exhibit a disso-
ciative state. During the next four days, however, he
showed gradual improvement. He would alternate from
being awake and oriented to being dissociative and
having decreased sensory and motor function, despite
the lack of a toxic or metabolic process. By the fourth
day of hospitalization, he had a significant increase in
sensory and motor function and was able to answer
questions appropriately. The dissociative states became
less frequent and of shorter duration. On the ninth day
of hospitalization, our patient was discharged home with
full recovery and without any objective neurological
abnormalities.
Figure 2 Post-operative axial CT of head showing no
intracranial pathology.
Figure 3 CT (sagittal view) of cervical region showing normal
post-operative changes.
Figure 4 Normal post-operative sagittal T1-weighted MRI of
patient’s head.
Figure 5 Normal post-operative sagittal T1-weighted MRI of
patient’s neck.
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Discussion
Cervical laminectomy and laminoplasty are routine neu-
rosurgical procedures to treat myelopathy secondary to
cervical stenosis. According to some studies, cervical
laminoplasty has over an 86% success rate [7]. However,
even this high success rate is sometimes challenged by
other unexplainable factors, such as seen in this case in
the post-operative phase [8].
Our patient presented post-operatively in a dissocia-
tive state with paralysis, anarthria and preservation of
consciousness. He was able to open his eyes to verbal
stimuli and preserved eye movement. Several factors
were considered, such as prolonged anesthetic effects,
inadequate reversal of narcotics, prolonged CNS depres-
sion from gabapentin/ketamine interaction, metabolic
abnormalities, hypoxia, infection, trauma, hemorrhage,
thrombosis leading to infarct, hematoma/abscess in the
spinal cord, and/or psychological causes. Organic causes,
with the exception of prolonged CNS depression from a
gabapentin/ketamine drug interaction, were excluded.
However, given our patient’s psychiatric history of
PTSD, conversion disorder could not be excluded [8].
David Han et al. (2007) describe a case in which, after
implantation of a spinal cord stimulator, a 42-year-old
woman presented with quadriplegia and lower facial
diplegia. She was able to open and blink her eyes. There
were no organic causes found to explain her condition.
A scopolamine patch had been placed prior to surgery.
In the PACU the patch was removed and 2 mg physos-
tigmine was given, which produced retching after three
minutes and no improvement in neurological symptoms.
After ruling out all organic factors, the patient was
found to have locked-in syndrome resulting from a con-
version disorder. She recovered in less than 24 hours
[9].
Locked-in syndrome is defined as quadriplegia and
anarthria with the preservation of consciousness.
Locked-in syndrome can be categorized into Classic,
Incomplete, and Total. Classic is characterized by quad-
riplegia, anarthria, vertical eye movement, and preserved
conscious. Incomplete is the same as classic, except with
voluntary movements in addition to vertical eye move-
ment. Total is characterized by a complete loss of mobi-
lity and loss of any form of communication, but
preservation of consciousness [8-10].
Although conversion disorder remained a plausible
answer, prolonged CNS depression from a gabapentin/
ketamine drug interaction could not be excluded. This
was especially true since our patient had undergone sev-
eral other surgeries in the past without such a dissocia-
tive post-operative recovery. In those cases, however,
anesthetics included propofol, fentanyl, and inhalational
anesthetic agents. To reiterate, in those previous
surgeries, ketamine was not used and our patient did
not have a complicated post-operative phase.
As an out-patient, our patient took a high dose of
gabapentin (900 mg three times a day) for chronic pain.
Gabapentin is structurally related to gamma-aminobuty-
ric acid (GABA), a neurotransmitter that plays an
important role in neuronal excitability. The exact
mechanism by which gabapentin exerts its properties is
not known, however the drug is thought to enhance the
release or actions of GABA [11]. According to one
study, peri-operative gabapentin can effectively reduce
post-operative pain, opioid consumption, and opioid-
related adverse effects after surgery. According to the
same study, one of the adverse effects of using peri-
operative gabapentin is prolonged sedation [12].
Peri-operative ketamine has also been shown to effec-
tively reduce post-operative analgesic requirements.
Ketamine is a commonly used anesthetic agent that
works as an N-methyl-D-aspartic acid (NMDA) antago-
nist. NMDA is a synthetic compound that mimics the
neurotransmitter glutamate–an excitatory neurotrans-
mitter of the nervous system. Release of glutamate acti-
vates post-synaptic glutamate and NMDA receptors.
Ketamine is frequently referred to as a dissociative anes-
thetic, because it interrupts association pathways in the
brain. One of the adverse effects of using peri-operative
ketamine is prolonged recovery time [13,14].
Together, gabapentin and ketamine could have con-
tributed to the prolonged recovery. An online source
relates that these drugs used together may have a syner-
gistic effect and that the patient should be monitored
for prolonged CNS and respiratory depression [6]. Sev-
eral studies have shown how the use of ketamine with
other CNS depressants can potentiate CNS depression
[15,16].
Our patient took 900 mg gabapentin three times daily
up until the morning of his procedure. A total of 100
mg of ketamine was administered during his procedure.
Ketamine was selected because of our patient’s history
of asthma and to reduce his post-operative pain medica-
tion requirement. To examine the interaction of these
drugs, one must further investigate the bioavailability of
these drugs.
Gabapentin elimination half-life is five to seven hours,
while the ketamine metabolite half-life is two and a half
hours. Gabapentin is eliminated from the systemic cir-
culation by renal excretion. Ketamine is metabolized in
the liver and excreted by the kidneys [17,18].
After parenteral administration of ketamine, high con-
centrations are found in body fat, liver, lung and brain.
Peripheral fat distribution, along with redistribution
from the CNS to slower equilibrating peripheral tissues,
suggests that ketamine is bioavailable beyond its initial
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peak effect. Nevertheless, ketamine has a wide margin of
safety. Unintentional administrations of overdoses of
ketamine have been followed by prolonged but complete
recovery [18].
Conclusion
Although this case by itself is not enough evidence to
substantiate a true adverse reaction between gabapentin
and ketamine, it is enough to warrant further investiga-
tion. With the rising numbers of PTSD and chronic
pain patients, it is crucial for the clinician to remember
cases such as this one if faced with an unusual post-
operative recovery phase.
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